Education
About Us
Working with TipRanks
Follow Us
Algernon Pharmaceuticals (AGNPF)
:AGNPF
N,N-Dimethyltryptamine
Stroke
Phase I
Active Not Recruiting
Single and Repeat Doses of DMT in Healthy Subjects
Sep 14, 2022
―
Np-120 (Ifenprodil)
Covid
Phase II/III
Completed
Safety and Efficacy of NP-120 (Ifenprodil) for the Treatment of Hospitalized Patient With Confirmed COVID-19 Disease
May 08, 2020
―
Ifenprodil
Idiopathic Pulmonary Fibrosis
Phase II
Completed
Efficacy, Safety and Tolerability of NP-120 on Idiopathic Pulmonary Fibrosis and Its Associated Cough
Mar 20, 2020
―
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases:
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Algernon Pharmaceuticals (AGNPF) have in its pipeline
AGNPF is currently developing the following drugs: N,N-Dimethyltryptamine, Np-120 (Ifenprodil), Ifenprodil. These drug candidates are in various stages of clinical development as the company works toward FDA approval.